Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 7NIH 7NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 3Gynecologic 3Gastrointestinal 2Breast 2Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Solid Tumor 1

Interventions

Injections 98pembrolizumab 90Carboplatin 56Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17olaparib 13Rifampin 13Itraconazole 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11Drug Therapy 11sintilimab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Magnetic Resonance Spectroscopy × Other solid neoplasm × Clear all
NCT05989997 2025-09-16

Phase I Clinical Trial of 68Ga-NOTA-SNA002

SmartNuclide Biopharma

Phase 1 Completed
17 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡